Atossa Therapeutics, Inc. (ATOS)
2.54
-0.10
(-3.79%)
USD |
NASDAQ |
Aug 28, 11:21
Atossa Therapeutics Total Assets (Quarterly) : 32.28M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.28M |
| March 31, 2026 | 37.94M |
| December 31, 2025 | 47.61M |
| September 30, 2025 | 58.01M |
| June 30, 2025 | 64.52M |
| March 31, 2025 | 70.75M |
| December 31, 2024 | 76.44M |
| September 30, 2024 | 79.48M |
| June 30, 2024 | 85.86M |
| March 31, 2024 | 91.09M |
| December 31, 2023 | 96.25M |
| September 30, 2023 | 101.70M |
| June 30, 2023 | 108.36M |
| March 31, 2023 | 116.20M |
| December 31, 2022 | 123.53M |
| September 30, 2022 | 126.72M |
| June 30, 2022 | 134.05M |
| March 31, 2022 | 137.48M |
| December 31, 2021 | 141.26M |
| September 30, 2021 | 143.02M |
| June 30, 2021 | 145.87M |
| March 31, 2021 | 141.08M |
| December 31, 2020 | 42.84M |
| September 30, 2020 | 11.44M |
| June 30, 2020 | 10.21M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.81M |
| December 31, 2019 | 14.50M |
| September 30, 2019 | 16.60M |
| June 30, 2019 | 18.61M |
| March 31, 2019 | 21.02M |
| December 31, 2018 | 11.72M |
| September 30, 2018 | 14.12M |
| June 30, 2018 | 16.58M |
| March 31, 2018 | 5.980M |
| December 31, 2017 | 8.164M |
| September 30, 2017 | 3.635M |
| June 30, 2017 | 4.709M |
| March 31, 2017 | 2.303M |
| December 31, 2016 | 4.144M |
| September 30, 2016 | 6.278M |
| June 30, 2016 | 3.285M |
| March 31, 2016 | 5.10M |
| December 31, 2015 | |
| September 30, 2015 | 12.36M |
| June 30, 2015 | 16.56M |
| March 31, 2015 | 13.80M |
| December 31, 2014 | 11.76M |
| September 30, 2014 | 16.77M |
| June 30, 2014 | 19.82M |
| March 31, 2014 | 22.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Immix Biopharma, Inc. | 239.11M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.451M |
| Shareholders Equity (Quarterly) | 26.83M |
| Current Ratio | 5.689 |